Giuliani鈥檚 Consulting Firm Helped Halt Purdue Opioid Investigation In Florida
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue鈥檚 marketing of OxyContin.
The independent source for health policy research, polling, and news.
261 - 280 of 389 Results
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue鈥檚 marketing of OxyContin.
Researchers combined the number of suicide deaths with those associated with drug overdoses in an effort to better grasp the overlap between these two public health epidemics.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?
Rather than go cold turkey, inmates increasingly have the option to take medication to help beat addiction to opioids and other substances. But some warn these substitute drugs serve as another crutch 鈥 and a costly one at that.
One doctor in Kansas works to make sure every hospital in the state can provide the soft start, ideally with their mothers, that babies with neonatal abstinence syndrome need.
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients鈥 right to opioid treatment for pain.
A study published Thursday shows that doctors, dentists and other medical providers cut overall opioid dosages by nearly 10 percent after receiving notification of a death from a medical examiner and information on safe prescribing.
An approach known as Community Reinforcement and Family Training, or CRAFT, coaches families to deal with a loved one's substance abuse with compassion.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
Gabapentin, a medication approved to help patients with nerve pain or epilepsy, is being abused by people addicted to opioids to help prolong their high or stave off withdrawal from other drugs. Kaiser Health News reporter Carmen Heredia Rodriguez talks about the problem during a wide-ranging health discussion on the NPR program "On Point."
Fentanyl and other painkillers marketed as safer than Purdue Pharma鈥檚 blockbuster drug left their own trail of overdose deaths.
States are passing laws that limit a doctor's ability to prescribe opioids. Doctors and patients alike are wrestling with what that means in cases of chronic pain.
KHN senior correspondent Fred Schulte talks about a cache of files detailing Purdue Pharma鈥檚 early OxyContin marketing plan.
The nation鈥檚 effort to combat this public health crisis could get caught in the crossfire of the Trump administration鈥檚 trade policies.
Efforts to provide care that integrates physical and mental health services are spreading, partly because untreated mental health conditions negatively affect physical health and escalate health care costs.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
As the opioid epidemic rages, a Johns Hopkins surgeon and researcher is leading an effort to curb overprescribing by offering procedure-specific guidelines to ensure that post-surgical patients leave the hospital with enough, but not too much, pain medication.
Patients revived from an opioid overdose who get methadone or Suboxone treatment for addiction afterward are much more likely to be alive a year later, says a study published in the Annals of Internal Medicine.
New Hampshire parents who are trying to overcome opioid abuse face a ticking clock and limited state resources to try to keep their parental rights.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
漏 2026 KFF